Susquehanna Portfolio Strategies, LLC Collegium Pharmaceutical, Inc Transaction History
Susquehanna Portfolio Strategies, LLC
- $4.58 Trillion
- Q2 2025
A detailed history of Susquehanna Portfolio Strategies, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 7,340 shares of COLL stock, worth $310,482. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,340Holding current value
$310,482% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding COLL
# of Institutions
240Shares Held
35.9MCall Options Held
52.5KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$245 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3.16MShares$134 Million2.15% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$112 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.23MShares$94.2 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.58MShares$67 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.44B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...